Minimal disease activity (MDA) in atopic dermatitis (AD) is a concept that combines a treat-to-target therapeutic strategy with the principle of shared decision-making. The aim is to achieve a state in which AD has minimal impact on the patient’s life by achieving pre-agreed disease control goals through the use of an appropriate systemic therapy. Prof. Dr. med. Schmid-Grendelmeier gave a practice-oriented overview of the MDA concept in his presentation.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- From the late residual valve to independent therapy
Tricuspid interventions 2025
- Brain health
News from the Swiss Brain Health Plan (SBHP) 2023-2033
- Friedreich's ataxia
Treatment options have improved
- Focus on prevention
Colorectal cancer screening – an update
- Late-Breaking Science
Antithrombotics & rhythm
- Prostate cancer
Diagnosis without drama – ESMO 2025 under the banner of differentiated patient management
- Pneumococcal conjugate vaccine (PCV)
Best possible serotype coverage in the respective age group
- Psoriasis: intervening in the inflammatory cascade